more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

Sernova Biotherapeutics Advances Toward Diabetes Solutions with FDA Orphan Drug Designation and Strengthened Capital Base

  ()
Sernova Biotherapeutics leverages its Cell Pouch technology and recent FDA orphan drug designation to address type 1 and type 3c diabetes amid a growing global market, supported by improved financial stability for retail investors.
Tags: Regenerative MedicineMedical DevicesLife Sciences Tools & Diagnostics

Biotech Secures Major FDA Orphan Drug Designation for Diabetes Treatment

  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTC; PSH:XETRA) announces it has been granted orphan drug designation for autologous islet transplantation (AIT) for preventing diabetes following a total pancreatectomy.
Tags: Regenerative MedicineMedical DevicesLife Sciences Tools & Diagnostics

Genetic Medicines Co. Reveals Transformative 'Only-of-Its-Kind' AAV Therapy Milestone

  ()
MeiraGTx Holdings Plc (MGTX:NASDAQ) reports 3-year gene therapy results, secures US$100M funding, and advances late-stage pipeline, signaling major commercial potential.
Tags: Biotechnology / PharmaceuticalsRegenerative Medicine

Showing Results: 1 to 3 of 3